Clinical Trials Directory

Trials / Terminated

TerminatedNCT00721097

Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

Status
Terminated
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Asthma is a chronic inflammatory disease, affecting up to 10 % of the general population in developed countries. Corticosteroids are necessary to control symptoms, but induce adverse events sometimes intolerable. In severe asthma, which represent 5 to 10% of global asthma, corticosteroids frequently fail to prevent severe exacerbations, leading to emergency care, hospitalization and sometimes death. The aim of this study is to identify predictive factors specific for exacerbation outcome which will lead to a minor increase in treatment in order to prevent exacerbations, while minimizing drug adverse effects.

Conditions

Interventions

TypeNameDescription
OTHERspirometry, and blood takeneach month during one year

Timeline

Start date
2008-06-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2008-07-23
Last updated
2013-09-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00721097. Inclusion in this directory is not an endorsement.